JZP258
JZP258-406
Approved small_molecule completed
Quick answer
JZP258 for Narcolepsy is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Narcolepsy
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed